001     137035
005     20250321140649.0
024 7 _ |a 10.1007/s00234-013-1219-9
|2 doi
024 7 _ |a pmid:23811957
|2 pmid
024 7 _ |a 0028-3940
|2 ISSN
024 7 _ |a 1432-1920
|2 ISSN
024 7 _ |a altmetric:1610175
|2 altmetric
037 _ _ |a DZNE-2020-03357
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Singer, Oliver C
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Periprocedural aspects in mechanical recanalization for acute stroke: data from the ENDOSTROKE registry.
260 _ _ |a Heidelberg
|c 2013
|b Springer
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2013-06-28
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2013-09-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1742562366_11985
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The ENDOSTROKE registry aims to accompany the spreading use of endovascular stroke treatment (EVT) in academic and non-academic hospitals. This analysis focuses on preprocedural imaging, patient handling and referral, as well as on different treatment modalities in mechanical recanalization.Data for this study were from observational registry study in 12 stroke centers in Germany and Austria with online assessment of prespecified variables concerning endovascular stroke therapy.Data from 734 patients undergoing EVT were analyzed. Preferred imaging modality prior to EVT was CT (83 %) and CTA (78 %). In 95 %, EVT was performed under general anesthesia. In 55 % of patients, a combination of intravenous (IV) thrombolysis and EVT was used, followed by pure EVT (25 %), intra-arterial (IA) thrombolysis plus EVT (13 %) and IV + IA thrombolysis plus EVT (7 %). Intrahospital time delay until start of EVT was 91 and 99 min in anterior and vertebrobasilar circulation stroke, respectively. Average duration of EVT was 60 min. Overall thrombolysis in myocardial infarction grade 2/3 recanalization rate was 85 %. Stent retrievers were used in 75 %, being associated with higher recanalization rates than non-stent retrievers. Hemorrhagic complications (symptomatic and asymptomatic) occurred in 12 %. Overall vessel occlusion time was approximately 60 min longer in patients being referred from a primary care hospital for EVT.This study gives an overview of procedure-related factors in current EVT practice. It gives estimates on preprocedural imaging modalities, periprocedural handling, and treatment combinations used for EVT. Patient referral for EVT from primary care hospitals is associated with longer vessel occlusion times.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2013-06-28
|2 Crossref
|u http://www.springer.com/tdm
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Germany: epidemiology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Mechanical Thrombolysis: statistics & numerical data
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Operative Time
|2 MeSH
650 _ 2 |a Perioperative Care: statistics & numerical data
|2 MeSH
650 _ 2 |a Postoperative Complications: diagnosis
|2 MeSH
650 _ 2 |a Postoperative Complications: epidemiology
|2 MeSH
650 _ 2 |a Prevalence
|2 MeSH
650 _ 2 |a Radiography
|2 MeSH
650 _ 2 |a Registries
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Stents: statistics & numerical data
|2 MeSH
650 _ 2 |a Stroke: diagnostic imaging
|2 MeSH
650 _ 2 |a Stroke: epidemiology
|2 MeSH
650 _ 2 |a Stroke: surgery
|2 MeSH
650 _ 2 |a Treatment Outcome
|2 MeSH
700 1 _ |a Haring, Hans-Peter
|b 1
700 1 _ |a Trenkler, Johannes
|b 2
700 1 _ |a Nolte, Christian H
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Bohner, Georg
|b 4
700 1 _ |a Neumann-Haefelin, Tobias
|b 5
700 1 _ |a Hofmann, Erich
|b 6
700 1 _ |a Reich, Arno
|b 7
700 1 _ |a Wiesmann, Martin
|b 8
700 1 _ |a Niederkorn, Kurt
|b 9
700 1 _ |a Deutschmann, Hannes
|b 10
700 1 _ |a Bussmeyer, Matthias
|b 11
700 1 _ |a Mpotsaris, Anastasios
|b 12
700 1 _ |a Stoll, Anett
|b 13
700 1 _ |a Bormann, Albrecht
|b 14
700 1 _ |a Petzold, Gabor Claus Julius Peter
|0 P:(DE-2719)2810273
|b 15
|u dzne
700 1 _ |a Urbach, Horst
|b 16
700 1 _ |a Jander, Sebastian
|b 17
700 1 _ |a Turowski, Bernd
|b 18
700 1 _ |a Weimar, Christian
|b 19
700 1 _ |a Schlamann, Marc
|b 20
700 1 _ |a Gröschel, Klaus
|b 21
700 1 _ |a Boor, Stephan
|b 22
700 1 _ |a Berkefeld, Joachim
|b 23
700 1 _ |a Group, ENDOSTROKE Study
|b 24
700 1 _ |a Poltrum, Birgit
|b 25
700 1 _ |a Gattringer, Thomas
|b 26
700 1 _ |a Schneider, Christine
|0 P:(DE-HGF)0
|b 27
700 1 _ |a Bode, Felix J
|0 P:(DE-HGF)0
|b 28
700 1 _ |a Gliem, Michael
|b 29
700 1 _ |a Lee, John-Ih
|b 30
700 1 _ |a Brenck, Johannes
|b 31
700 1 _ |a Strenge, Dana
|b 32
700 1 _ |a You, Se-Jong
|b 33
700 1 _ |a Tütüncü, Serdar
|b 34
700 1 _ |a Nußbaumer, Karin
|b 35
700 1 _ |a Sonnberger, Michael
|b 36
700 1 _ |a Meggeneder, Jessica
|b 37
773 1 8 |a 10.1007/s00234-013-1219-9
|b : Springer Science and Business Media LLC, 2013-06-28
|n 9
|p 1143-1151
|3 journal-article
|2 Crossref
|t Neuroradiology
|v 55
|y 2013
|x 0028-3940
773 _ _ |a 10.1007/s00234-013-1219-9
|g Vol. 55, no. 9, p. 1143 - 1151
|0 PERI:(DE-600)1462953-7
|n 9
|q 55:9<1143 - 1151
|p 1143-1151
|t Neuroradiology
|v 55
|y 2013
|x 0028-3940
856 4 _ |u https://pub.dzne.de/record/137035/files/DZNE-2020-03357_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/137035/files/DZNE-2020-03357_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:137035
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)2810273
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2013
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURORADIOLOGY : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)1013020
|k AG Petzold
|l Vascular Neurology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013020
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1056/NEJMoa1212793
|2 Crossref
|o 10.1056/NEJMoa1212793
999 C 5 |9 -- missing cx lookup --
|a 10.1056/NEJMoa1213701
|2 Crossref
|o 10.1056/NEJMoa1213701
999 C 5 |9 -- missing cx lookup --
|a 10.1056/NEJMoa1214300
|2 Crossref
|o 10.1056/NEJMoa1214300
999 C 5 |9 -- missing cx lookup --
|a 10.1161/STROKEAHA.110.580266
|2 Crossref
|o 10.1161/STROKEAHA.110.580266
999 C 5 |9 -- missing cx lookup --
|a 10.3174/ajnr.A2006
|2 Crossref
|o 10.3174/ajnr.A2006
999 C 5 |9 -- missing cx lookup --
|a 10.1161/STROKEAHA.109.574129
|2 Crossref
|o 10.1161/STROKEAHA.109.574129
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.CIR.76.1.142
|2 Crossref
|o 10.1161/01.CIR.76.1.142
999 C 5 |9 -- missing cx lookup --
|a 10.1161/01.STR.0000082721.62796.09
|2 Crossref
|o 10.1161/01.STR.0000082721.62796.09
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0140-6736(98)08020-9
|2 Crossref
|o 10.1016/S0140-6736(98)08020-9
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.WNL.0000125320.53244.FA
|2 Crossref
|o 10.1212/01.WNL.0000125320.53244.FA
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(12)70203-X
|2 Crossref
|o 10.1016/S1474-4422(12)70203-X
999 C 5 |9 -- missing cx lookup --
|a 10.1161/STROKEAHA.110.578997
|2 Crossref
|o 10.1161/STROKEAHA.110.578997
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000250341.38014.d2
|2 Crossref
|o 10.1212/01.wnl.0000250341.38014.d2
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000088063
|2 Crossref
|o 10.1159/000088063
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0140-6736(10)60491-6
|2 Crossref
|o 10.1016/S0140-6736(10)60491-6
999 C 5 |9 -- missing cx lookup --
|a 10.1161/CIRCULATIONAHA.112.000506
|2 Crossref
|o 10.1161/CIRCULATIONAHA.112.000506
999 C 5 |9 -- missing cx lookup --
|a 10.1161/STROKEAHA.111.639112
|2 Crossref
|o 10.1161/STROKEAHA.111.639112
999 C 5 |9 -- missing cx lookup --
|a 10.1161/STROKEAHA.109.574194
|2 Crossref
|o 10.1161/STROKEAHA.109.574194
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e31826959c2
|2 Crossref
|o 10.1212/WNL.0b013e31826959c2
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0140-6736(12)61384-1
|2 Crossref
|o 10.1016/S0140-6736(12)61384-1


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21